Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide
- PMID: 1191350
- DOI: 10.1002/art.1780180513
Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide
Abstract
Ten patients with Wegener's granulomatosis were treated with cyclophosphamide and followed for periods up to 7 years. In all cases cyclophosphamide induced complete remissions. The mean duration of remission (to date) was 38 months. Six patients have been in remission for a mean of 46 months after cyclophosphamide was discontinued; 2 have been disease-free for 7 years. Of the 10 patients treated, only 1 relapsed and she responded to a second course of cyclophosphamide. These results indicate that cyclophosphamide is the drug of choice in Wegener's granulomatosis. The long-term effectiveness of this drug suggests that it may induce permanent remissions in certain patients with Wegener's granulomatosis.
Similar articles
-
Diagnostic and therapeutic aspects of the surgical approach to Wegener's granulomatosis.J Thorac Cardiovasc Surg. 1979 Mar;77(3):331-7. J Thorac Cardiovasc Surg. 1979. PMID: 762975
-
Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.Am J Med. 2003 Apr 15;114(6):463-9. doi: 10.1016/s0002-9343(03)00077-9. Am J Med. 2003. PMID: 12727579 Clinical Trial.
-
Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.Ann Rheum Dis. 2004 Oct;63(10):1307-11. doi: 10.1136/ard.2003.019125. Epub 2004 May 6. Ann Rheum Dis. 2004. PMID: 15130900 Free PMC article. Review.
-
Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide.Am J Med. 1980 Mar;68(3):458-60. doi: 10.1016/0002-9343(80)90121-7. Am J Med. 1980. PMID: 6987874
-
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.Ann Intern Med. 1983 Jan;98(1):76-85. doi: 10.7326/0003-4819-98-1-76. Ann Intern Med. 1983. PMID: 6336643 Review.
Cited by
-
Wegener's granulomatosis and autoantibodies to neutrophil antigens.Ulster Med J. 1988 Oct;57(2):137-40. Ulster Med J. 1988. PMID: 3068870 Free PMC article.
-
Vasculitis and granulomatosis of the respiratory tract.Thorax. 1982 Feb;37(2):81-7. doi: 10.1136/thx.37.2.81. Thorax. 1982. PMID: 7043772 Free PMC article. Review. No abstract available.
-
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis.BMJ. 1989 Aug 12;299(6696):419-22. doi: 10.1136/bmj.299.6696.419. BMJ. 1989. PMID: 2506999 Free PMC article.
-
Editorial: Immunosuppressive therapy in SLE-a reappraisal.Br Med J. 1976 Apr 10;1(6014):856-7. doi: 10.1136/bmj.1.6014.856-a. Br Med J. 1976. PMID: 1260380 Free PMC article. No abstract available.
-
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.Pharmacoeconomics. 2014 Dec;32(12):1171-83. doi: 10.1007/s40273-014-0189-z. Pharmacoeconomics. 2014. PMID: 25059204 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources